Imara announces fda clearance of investigational new drug application (ind) for tovinontrine (imr-687) for heart failure with preserved ejection fraction (hfpef)

Expanding patient base and potential of imara's small molecule oral inhibitor of phosphodiesterase-9 (pde9) alongside hemoglobin disorders
ELVN Ratings Summary
ELVN Quant Ranking